West Pharmaceutical Services (WST) Other Gross PP&E Adjustments (2009 - 2026)

West Pharmaceutical Services' Other Gross PP&E Adjustments history runs 18 years deep, the most recent figure standing at $3.1 billion for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments rose 7.26% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (up 7.26% YoY), while the FY2025 annual figure was $3.1 billion, up 7.81% from the prior year.
• Other Gross PP&E Adjustments came in at $3.1 billion for Q1 2026 at West Pharmaceutical Services, roughly flat from $3.1 billion in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.1 billion in Q3 2025 to a low of $2.1 billion in Q3 2022.
• A 5-year average of $2.7 billion and a median of $2.7 billion in 2024 frame the typical range for Other Gross PP&E Adjustments.
• Across the five-year window, Other Gross PP&E Adjustments rose 2.81% in 2022 and advanced 16.96% in 2023, its largest moves.
• West Pharmaceutical Services' Other Gross PP&E Adjustments stood at $2.3 billion in 2022, then gained by 15.63% to $2.6 billion in 2023, then climbed by 9.19% to $2.9 billion in 2024, then gained by 7.81% to $3.1 billion in 2025, then rose by 0.21% to $3.1 billion in 2026.
• According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered $3.1 billion, $3.1 billion, and $3.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison